The peptide fragments generated by tumor-resident MMP-9 and released into the bloodstream – their quantities and identities presented in our comprehensive analyses here – strongly correlate with enzymatic expression and reflect the treatment effect using a novel nanovector-enabled siRNA delivery strategy. The gene discussed is MMP9; the disease is neoplasm.